# COVID-19 in Rheumatic Inflammatory Diseases Under Immuno-suppressive Drugs

> **NCT04530682** · — · COMPLETED · sponsor: **University Hospital, Montpellier** · enrollment: 163 (actual)

## Conditions studied

- Chronic Inflammatory Rheumatism

## Interventions

- **BIOLOGICAL:** Biological samples

## Key facts

- **NCT ID:** NCT04530682
- **Lead sponsor:** University Hospital, Montpellier
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-05
- **Primary completion:** 2022-06-23
- **Final completion:** 2024-02-15
- **Target enrollment:** 163 (ACTUAL)
- **Last updated:** 2024-04-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04530682

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04530682, "COVID-19 in Rheumatic Inflammatory Diseases Under Immuno-suppressive Drugs". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT04530682. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*